Safety and immunogenicity of a recombinant tetravalent dengue vaccine in 9-16 year olds: a randomized, controlled, phase II trial in Latin America. (Q40233569)
Jump to navigation
Jump to search
scientific article published on October 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and immunogenicity of a recombinant tetravalent dengue vaccine in 9-16 year olds: a randomized, controlled, phase II trial in Latin America. |
scientific article published on October 2013 |
Statements
Safety and immunogenicity of a recombinant tetravalent dengue vaccine in 9-16 year olds: a randomized, controlled, phase II trial in Latin America (English)
Luis Á Villar
Doris M Rivera-Medina
Mark Boaz
Linda Starr-Spires
Manoj Thakur
Betzana Zambrano
María C Miranda
Enrique Rivas
1 October 2013